Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPIDE-BCV for Ebola
PACTR201411000939962Completed
- Sponsor
- University of Oxford
- Start
- Dec 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of brincidofovir in Ebola virus disease (EVD) (2 arms), sponsored by University of Oxford. Primary endpoint: Mortality at Day 14 after entry into the trial. Started Dec 2014; status: completed.
02
Drugs
brincidofovir
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on PACTR201411000939962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201411000939962.